Events And
Presentations

GLP-1-Based Therapeutics Summit

May 15, 2024 at 10:00 AM EDT

Title: Focusing on the Use of GLP-1s in Treating MASH & Fatty Liver Disease

Speaker: Dr. Scott Harris, Chief Medical Officer, Altimmune

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe